
In terms of important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs, writes Bagrat Lalayan.
Bagrat Lalayan, M.D., Ph.D., is founder of Innovapharm and Victoria Consulting LLC (Armenia), and former GM of Armenian affiliates of Servier Laboratories (France), Roche (Switzerland).

In terms of important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs, writes Bagrat Lalayan.

Bagrat Lalayan presents an overview of osteoporosis treatment market and offers vision for future business strategies.

Bagrat Lalayan presents an overview of osteoporosis treatment market and offers vision for future business strategies.

The era of complex biological drugs requires sales reps with more advanced knowledge, write Barat Lalayan.

Pharma and biotech needs cultivate fast-performing leadership in our companies, writes Bagrat Lalayan. Here, he outlines a model to get the best results in a competitive business environment.

Published: May 18th 2017 | Updated:

Published: July 24th 2017 | Updated:

Published: December 6th 2017 | Updated:

Published: December 6th 2017 | Updated:

Published: March 31st 2018 | Updated: